Technologies

time icon Aug. 16, 2012

Preservation of tissues in vivo and in vitro

Technology description

These small peptide molecules protect cells from death in conditions that normally stress and kill them. These non-toxic, membrane permeable molecules related to Ku70 work through the Bax pathway very early in apoptosis prior to caspase activation. Therapeutic uses include minimizing tissue damage associated with transplantation, stroke, cancer, heart attack and neurological injury. Both in vivo and in vitro models show therapeutic utility. In rats, Bax peptide therapy prevented retinal degeneration after optic nerve injury. Mice with acute liver failure given monkey hepatocytes cultured with peptide had prolonged survival and better outcomes after liver transplant. Peptide blocks apoptosis in vitro in a very broad range of tissue types. Issued patent 7,314,866 Divisionals and continuations in prosecution

Application area

Therapeutic molecule to prevent long term tissue damage after injury
Media additive to prolong solid organ or cellular viability in transplantation
Blocks binding of bacterial and viral pathogens at the cell surface
To prevent cell death in non-cancerous tissues as a result of radiation or chemotherapy

Advantages

Inventor Shigemi Matsuyama, Ph.D. has demonstrated efficacy and activity across multiple species and various stresses that causes Bax-mediated cell death including apoptosis, necrotic and autophagic cell death. Bax peptides more effective in blocking programmed cell death than the pan-caspase inhibitor z-VAD-fmk without the associated toxicity.

由于技术保密工作限制,技术信息无法完全展现,请通过邮箱或短信联系我们,获取更多技术资料。

More information

Categories
  • Pathology
  • Diagnosis and treatment
Keywords:

monkey hepatocytes cultured

minimizing tissue damage

optic nerve injury

acute liver failure

peptide blocks apoptosis

下载 PDF 文档


感兴趣

Contact us

知繁业茂-yintrust logo知繁业茂-Branchly Innovation logo 知繁业茂-autmasia logo迈科技 logo